Format

Send to

Choose Destination
See comment in PubMed Commons below
Asian Cardiovasc Thorac Ann. 2015 May;23(4):467-70. doi: 10.1177/0218492314534659. Epub 2014 May 16.

Remarkable 23-year survival after bilateral thoracic melanoma metastasectomy.

Author information

  • 1Department of Surgery and Anatomy, Ribeirão Preto School of Medicine, University of São Paulo, São Paulo, Brazil.
  • 2Department of Pathology, Ribeirão Preto School of Medicine, University of São Paulo, São Paulo, Brazil.
  • 3Department of Surgery and Anatomy, Ribeirão Preto School of Medicine, University of São Paulo, São Paulo, Brazil prbevora@gmail.com.

Abstract

The prognosis of patients with metastatic melanoma is poor, with an annual risk of death of approximately 20% during the first 3 years. The survival average is only 6 to 8 months, and the 5-year survival rate is around 5%. This report describes a remarkable clinical outcome of complete resection of pulmonary metastatic melanoma. The 72-year-old woman is still alive without relapse 27 years after the initial diagnosis and 23 years after the last tumor excision. This remarkable outcome would indicate that the tumor cell population was composed of a particular metastatic phenotype.

© The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

KEYWORDS:

Disease-free survival; lung neoplasms; melanoma; metastasectomy; neoplasm metastasis

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk